GlassScriptPhysician profile
Syed Rizvi
NPI 1548371297
$778.31
in general payments reported to CMS, 2019-2025
9 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.11 · 2020: $62.85 · 2021: $70.66 · 2022: $123 · 2023: $163 · 2024: $29.85 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $284.29 | 2025 | Torus Stent Graft System, Endocross Device |
| Xeris Pharmaceuticals, INC. | $131.24 | 2022-2023 | Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $117.06 | 2022-2025 | |
| Boston Scientific Corporation | $90.75 | 2020-2021 | |
| Viiv Healthcare Company | $54.60 | 2020-2022 | |
| Lilly USA, LLC | $43.27 | 2022-2024 | Jardiance, Mounjaro |
| Recordati_rare_diseases_inc. | $30.02 | 2023-2024 | Signifor Lar, Isturisa |
| Lexicon Pharmaceuticals, INC. | $14.97 | 2023 | Inpefa |
| Nalpropion Pharmaceuticals LLC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.